Atlas Trials

Alector Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Alector Inc.

RecordFirmDate
Continuation Study for Latozinemab (NCT06111014)Alector Inc.2023-12-08
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS (NCT05053035)Alector Inc.2021-09-02
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease (NCT04592874)Alector Inc.2021-01-22
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3) (NCT04374136)Alector Inc.2020-07-23
A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101 (NCT04111666)Alector Inc.2019-12-14
A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2) (NCT03987295)Alector Inc.2019-09-27
First in Human Study for Safety and Tolerability of AL003. (NCT03822208)Alector Inc.2019-03-29
A Phase I Study for Safety and Tolerability of AL002. (NCT03635047)Alector Inc.2018-11-12
A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation (NCT03636204)Alector Inc.2018-09-14

Track Alector Inc. automatically

Every clearance here is in the API, with alerts when new ones post.